Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer|Breast Cancer
Interventions: DRUG: Neratinib|DRUG: Lapatinib|DRUG: Capecitabine
Sponsor: Puma Biotechnology, Inc.